首页> 美国卫生研究院文献>Journal of Clinical Medicine >The Integration of qSOFA with Clinical Variables and Serum Biomarkers Improves the Prognostic Value of qSOFA Alone in Patients with Suspected or Confirmed Sepsis at ED Admission
【2h】

The Integration of qSOFA with Clinical Variables and Serum Biomarkers Improves the Prognostic Value of qSOFA Alone in Patients with Suspected or Confirmed Sepsis at ED Admission

机译:将qSOFA与临床变量和血清生物标记物整合可提高qSOFA单独治疗在ED入院时怀疑或确诊败血症的患者的预后价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: The prognostic value of quick sepsis-related organ failure assessment (qSOFA) outside intensive care units has been criticized. Therefore, we aimed to improve its ability in predicting 30-day all-cause mortality, and in ruling out the cases at high risk of death among patients with suspected or confirmed sepsis at emergency department (ED) admission. Methods: This study is a secondary analysis of a prospective multicenter study. We built three predictive models combining qSOFA with the clinical variables and serum biomarkers that resulted in an independent association with 30-day mortality, in both 848 undifferentiated patients (Group 1) and in 545 patients definitively diagnosed with sepsis (Group 2). The models reaching the highest negative predictive value (NPV) with the minimum expenditure of biomarkers in Group 1 and in Group 2 were validated in two cohorts of patients initially held out due to missing data. Results: In terms of the area under the receiver-operating characteristic curve, all six models significantly exceeded qSOFA in predicting prognosis. An “extended” qSOFA (eqSOFA1) in Group 1 and an eqSOFA2 integrated with C-reactive protein and mid-regional proadrenomedullin (eqSOFA2+CRP+MR-proADM) in Group 2 reached the best NPV (0.94 and 0.93, respectively) and ease of use. eqSOFA1 and eqSOFA2+CRP+MR-proADM performed equally well in both the inception and validation cohorts. Conclusions: We have derived and validated two prognostic models that outweigh qSOFA in predicting mortality and in identifying the low risk of death among patients with suspected or confirmed sepsis at ED admission.
机译:背景:在重症监护病房以外进行败血症相关器官衰竭快速评估(qSOFA)的预后价值受到批评。因此,我们旨在提高其预测30天全因死亡率的能力,并排除急诊室(ED)怀疑或确诊为败血症的患者中高死亡风险的病例。方法:本研究是一项前瞻性多中心研究的辅助分析。我们建立了三种预测模型,将qSOFA与临床变量和血清生物标志物相结合,在848例未分化患者(第1组)和545例确诊为败血症的患者(第2组)中均导致30天死亡率的独立关联。在第1组和第2组中通过生物标志物的最低支出达到最高阴性预测值(NPV)的模型已在最初因缺少数据而被保留的两个队列中进行了验证。结果:就接收者操作特征曲线下的面积而言,所有六个模型在预测预后方面均显着超过qSOFA。第1组中的“扩展” qSOFA(eqSOFA1)和第2组中与C反应蛋白和中区肾上腺髓质素结合的eqSOFA2(eqSOFA2 + CRP + MR-proADM)达到了最佳NPV(分别为0.94和0.93)使用。 eqSOFA1和eqSOFA2 + CRP + MR-proADM在初始和验证队列中均表现良好。结论:我们已经推导并验证了两种预测模型,它们在预测死亡率以及在ED入院时怀疑或证实为败血症的患者中确定低死亡风险方面优于qSOFA。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号